According to EPN's membership guidelines, a partner is an organization, agency or association that provides financial or technical support or undertakes collaborative activities with the Network, or is an umbrella organization of which the Network is a member. EPN's partners include:
EHAIA is a joint undertaking of African churches, Northern churches and agencies, and the World Council of Churches (WCC). EHAIA enables churches in Africa to gain access to the information, training, networks and funding they need to help deal with HIV/AIDS in their communities. EHAIA works to help churches in Africa become "AIDS-competent churches"
Health Action International Africa (HAI Africa) is a growing regional network of consumers, NGOs, health care providers, academics and individuals in more than 20 countries in Sub-Saharan Africa promoting increased access to essential medicines, the essential medicines concept and the rational use of both modern and traditional medicines
The Ecumenical Advocacy Alliance is a broad ecumenical network for international cooperation in advocacy on global trade and HIV and AIDS. More than 90 churches and church-related organizations have joined the Alliance. The Alliance has identified the HIV and AIDS pandemic as one of the gravest challenges to health and also to the prospects of social and economic development and global security.
The World Council of Churches (WCC) is the broadest and most inclusive among the many organized expressions of the modern ecumenical movement. The WCC brings together more than 340 churches, denominations and church fellowships in over 100 countries and territories throughout the world. WCC programmes relate to the Council's five "historic" themes: faith and order; mission and ecumenical formation; justice, peace and creation; international affairs, peace and human security; and diakonia and solidarity.
WHO/EDM - Essential Drugs and Medicines Department of the World Health Organization aims to ensure therapeutically sound and cost-effective use of medicines by health professionals and consumers. Improving the use of medicines by health workers and the general public is crucial both to reducing morbidity and mortality from communicable and non-communicable diseases, and to containing drug expenditure. Ideally, therapeutically sound and cost-effective use of medicines by health professionals and consumers is achieved at all levels of the health system, and in both the public and the private sectors.